These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6587407)

  • 1. Relation of rates of excretion of urinary prostaglandin E metabolites to administration of angiotensin, aldosterone, and spironolactone in vivo.
    Fretland DJ; Cammarata PS
    Prostaglandins Leukot Med; 1984 Apr; 14(1):65-78. PubMed ID: 6587407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A facile reproducible radioimmunoassay of the mixed metabolites of prostaglandins E, suitable for measurement of relative differences of phospholipase/prostaglandin synthetase activity in vivo.
    Fretland DJ; Cammarata PS
    Prostaglandins Leukot Med; 1984 Apr; 14(1):79-96. PubMed ID: 6427792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adrenalectomy and spironolactone on urinary metabolites of aldosterone in rats.
    Gorsline J; Morris DJ
    Steroids; 1988; 51(1-2):81-99. PubMed ID: 3242168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity and structural relationships of steroids which affect phospholipase/prostaglandin synthetase, in vivo: a possible relation to blood pressure.
    Fretland DJ; Brown EA; Cammarata PS
    J Steroid Biochem; 1985 Mar; 22(3):305-10. PubMed ID: 3921768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of spironolactone on urinary excretion of immunoreactive prostaglandin E in essential hypertension and primary aldosteronism.
    Chiba S; Abe K; Yasujima M; Irokawa N; Seino M; Sakurai Y; Sato M; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1978 Apr; 124(4):297-305. PubMed ID: 663929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between aldosterone and renomedullary prostaglandins. Competitive action between aspirin and spironolactone.
    Papanicolaou N; Lefkos N; Massourides E; Marketos S; Papavassiliou J; Bariety J; Milliez P
    Experientia; 1977 Dec; 33(12):1632-4. PubMed ID: 590459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension.
    Chiba S; Abe K; Yasujima M; Irokawa N; Saito K; Sakurai Y; Ito T; Sato M; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 Nov; 129(3):249-56. PubMed ID: 524352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential effect of aldosterone and dexamethasone on pressor responses in adrenalectomized rats.
    Yagil Y; Krakoff LR
    Hypertension; 1988 Feb; 11(2):174-8. PubMed ID: 3343046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors.
    Campbell WB; Gomez-Sanchez CE; Adams BV; Schmitz JM; Itskovitz HD
    J Clin Invest; 1979 Dec; 64(6):1552-7. PubMed ID: 500824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension.
    Yasujima M; Abe K; Otsuka Y; Chiba S; Ritsu K; Irokawa N; Seino M; Sakurai Y; Saito K; Ito T; Yoshinaga K
    Tohoku J Exp Med; 1977 Nov; 123(3):271-8. PubMed ID: 601775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of aldosterone release by prostaglandin E in isolated rat adrenal glomerulosa cells.
    Horiuchi T; Tanaka K; Shimizu N
    Endocrinol Jpn; 1985 Aug; 32(4):529-36. PubMed ID: 2867894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on mechanisms of antinephritic action of SA-446 an angiotensin I converting enzyme inhibitor (1). A comparison with actions of spironolactone, kallidinogenase and saralasin.
    Suzuki Y; Ito M; Saito N
    Jpn J Pharmacol; 1986 Dec; 42(4):465-75. PubMed ID: 3027437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
    Virdis A; Neves MF; Amiri F; Viel E; Touyz RM; Schiffrin EL
    Hypertension; 2002 Oct; 40(4):504-10. PubMed ID: 12364354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells.
    Campbell WB; Gomez-Sanchez CE
    Endocrinology; 1985 Jul; 117(1):279-86. PubMed ID: 3924581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
    Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K
    Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II associated cardiac myocyte necrosis: role of adrenal catecholamines.
    Ratajska A; Campbell SE; Sun Y; Weber KT
    Cardiovasc Res; 1994 May; 28(5):684-90. PubMed ID: 8025914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aldosterone on urinary kallikrein and prostaglandin excretion in the rat.
    Fejes-Tóth G; Náray-Fejes-Tóth A
    J Physiol; 1984 Sep; 354():79-88. PubMed ID: 6592330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac aldosterone production in genetically hypertensive rats.
    Takeda Y; Yoneda T; Demura M; Miyamori I; Mabuchi H
    Hypertension; 2000 Oct; 36(4):495-500. PubMed ID: 11040225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of spironolactone on glucocorticoid-induced colonic cation transport.
    Bastl CP
    Am J Physiol; 1988 Dec; 255(6 Pt 2):F1235-42. PubMed ID: 3202186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.